SCHEDULE: T. Rowe Price Boosts Natera Stake to 8.9%

T. Rowe Price Associates, Inc. has reported an 8.9% beneficial ownership stake in Natera Inc., holding over 12.19 million shares of common stock.

Summary

• T. Rowe Price Associates, Inc. filed an Amendment No. 2 to Schedule 13G regarding its beneficial ownership in Natera Inc.
• The filing indicates T. Rowe Price Associates, Inc. beneficially owns 12,191,814 shares of Natera Inc. common stock.
• This ownership represents 8.9% of Natera Inc.'s common stock class.
• T. Rowe Price Associates, Inc. holds sole voting power over 11,740,295 shares and sole dispositive power over 12,156,248 shares.
• The date of the event which required this filing is June 30, 2025.
• T. Rowe Price Associates, Inc. is classified as an Investment Adviser (IA).

Sentiment

Score: 6

Explanation: The filing is a factual disclosure of a significant beneficial ownership stake by a major investment firm, T. Rowe Price Associates, Inc., in Natera Inc. While the filing itself does not contain performance data or forward-looking statements from Natera, a substantial institutional holding can be interpreted by the market as a sign of confidence.

Positives

• A significant beneficial ownership stake by a major institutional investor like T. Rowe Price Associates, Inc. can be interpreted as a vote of confidence in Natera Inc.

Future Outlook

NA

Industry Context

NA

Stakeholder Impact

• Shareholders: The disclosure of a significant institutional holding by T. Rowe Price may instill confidence among existing and potential shareholders, potentially influencing stock perception.

Key Dates

Keywords

Natera Inc, T. Rowe Price, Schedule 13G, Beneficial Ownership, Common Stock, Investment Adviser, Institutional Investor, Healthcare, Biotechnology, Diagnostics